Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · IEX Real-Time Price · USD
36.43
+0.34 (0.94%)
At close: Apr 24, 2024, 4:00 PM
34.97
-1.46 (-4.00%)
After-hours: Apr 24, 2024, 5:57 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.70 billion as of April 24, 2024. Its market cap has increased by 77.55% in one year.
Market Cap
1.70B
Enterprise Value
1.23B
1-Year Change
77.55%
Ranking
Category
Stock Price
$36.43
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.70B, an increase of 209.31%. That is a compound annual growth rate of 152.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 1.68B | 0.20% |
Apr 22, 2024 | 1.68B | -0.94% |
Apr 19, 2024 | 1.69B | 0.50% |
Apr 18, 2024 | 1.69B | -2.40% |
Apr 17, 2024 | 1.73B | -1.98% |
Apr 16, 2024 | 1.76B | 0.45% |
Apr 15, 2024 | 1.75B | -4.25% |
Apr 12, 2024 | 1.83B | -2.31% |
Apr 11, 2024 | 1.88B | -0.14% |
Apr 10, 2024 | 1.88B | -2.82% |
Apr 9, 2024 | 1.93B | -6.60% |
Apr 8, 2024 | 2.07B | 7.12% |
Apr 5, 2024 | 1.93B | 5.49% |
Apr 4, 2024 | 1.83B | -1.90% |
Apr 3, 2024 | 1.87B | 1.37% |
Apr 2, 2024 | 1.84B | -3.37% |
Apr 1, 2024 | 1.91B | -4.58% |
Mar 28, 2024 | 2.00B | -0.12% |
Mar 27, 2024 | 2.00B | 1.76% |
Mar 26, 2024 | 1.97B | -2.41% |
Mar 25, 2024 | 2.01B | 0.77% |
Mar 22, 2024 | 2.00B | -2.28% |
Mar 21, 2024 | 2.04B | 13.59% |
Mar 20, 2024 | 1.80B | 5.89% |
Mar 19, 2024 | 1.70B | 4.83% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alphatec Holdings | 1.76B |
Sana Biotechnology | 1.75B |
NeoGenomics | 1.71B |
Twist Bioscience | 1.68B |
Agios Pharmaceuticals | 1.68B |
Harmony Biosciences Holdings | 1.67B |
Myriad Genetics | 1.66B |
Amneal Pharmaceuticals | 1.66B |